MANILA, Philippines — The country’s vaccine screening authorities will validate the bribery accusations against China’s Sinovac Biotech which is eyeing to supply the Philippines with its coronavirus vaccine.
In a Dec. 4 report, US newspaper Washington Post said Sinovac Biotech had been found to have a record of bribing Chinese drug regulators to secure vaccine approvals, which had raised serious questions about its products’ safety.
READ: Bribery past hounds Chinese firm eyeing PH market for coronavirus vaccines
But Health Secretary Francisco Duque III assured Wednesday that the Food and Drug Administration (FDA), the vaccine experts panel, as well as the Single Joint Research…
Keep on reading: Duque: PH vaccine regulators on guard amid reported bribery allegations vs Sinovac